Harmony Biosciences (HRMY) is seeing a notable increase in bearish sentiment. With only eight days remaining until the company's earnings release, Ortex data indicates that a growing cohort of market participants is moving to open short positions. The convergence of retail crowd activity and institutional positioning suggests that traders are positioning for a potential downside surprise. Investors should monitor the borrow fee and share availability closely, as any sudden tightening in the lending market could signal an attempt to force a squeeze or a significant increase in conviction among short sellers.
Signal data sourced from Ortex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.